The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation

G Mowatt; G Scotland; C Boachie; M Cruickshank; J A Ford; C Fraser; L Kurban; T B Lam; A R Padhani; J Royle; T W Scheenen; E Tassie

doi:10.3310/hta17200

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation

G Mowatt
, G Scotland
, C Boachie
, M Cruickshank
, J A Ford
, C Fraser
, L Kurban
, T B Lam
, A R Padhani
, J Royle
, T W Scheenen
, E Tassie

Research output: Contribution to journal › Article › peer-review

108 Citations (Scopus)

Abstract

In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.

Original language	English
Pages (from-to)	vii-xix, 1-281
Journal	Health Technology Assessment
Volume	17
Issue number	20
DOIs	https://doi.org/10.3310/hta17200
Publication status	Published - May 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Biopsy
Cost-Benefit Analysis
Diffusion Magnetic Resonance Imaging
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Prostate
Prostatic Neoplasms

Access to Document

10.3310/hta17200

Cite this

Mowatt, G., Scotland, G., Boachie, C., Cruickshank, M., Ford, J. A., Fraser, C., Kurban, L., Lam, T. B., Padhani, A. R., Royle, J., Scheenen, T. W., & Tassie, E. (2013). The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation. Health Technology Assessment, 17(20), vii-xix, 1-281. https://doi.org/10.3310/hta17200

@article{3086ddd9b910444f9c251f58122067fb,

title = "The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation",

abstract = "In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.",

keywords = "Biopsy, Cost-Benefit Analysis, Diffusion Magnetic Resonance Imaging, Humans, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Male, Prostate, Prostatic Neoplasms",

author = "G Mowatt and G Scotland and C Boachie and M Cruickshank and Ford, \{J A\} and C Fraser and L Kurban and Lam, \{T B\} and Padhani, \{A R\} and J Royle and Scheenen, \{T W\} and E Tassie",

year = "2013",

month = may,

doi = "10.3310/hta17200",

language = "English",

volume = "17",

pages = "vii--xix, 1--281",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Journals Library",

number = "20",

}

Mowatt, G, Scotland, G, Boachie, C, Cruickshank, M, Ford, JA, Fraser, C, Kurban, L, Lam, TB, Padhani, AR, Royle, J, Scheenen, TW & Tassie, E 2013, 'The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation', Health Technology Assessment, vol. 17, no. 20, pp. vii-xix, 1-281. https://doi.org/10.3310/hta17200

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation. / Mowatt, G; Scotland, G; Boachie, C et al.
In: Health Technology Assessment, Vol. 17, No. 20, 05.2013, p. vii-xix, 1-281.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy

T2 - A systematic review and economic evaluation

AU - Mowatt, G

AU - Scotland, G

AU - Boachie, C

AU - Cruickshank, M

AU - Ford, J A

AU - Fraser, C

AU - Kurban, L

AU - Lam, T B

AU - Padhani, A R

AU - Royle, J

AU - Scheenen, T W

AU - Tassie, E

PY - 2013/5

Y1 - 2013/5

N2 - In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.

AB - In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.

KW - Biopsy

KW - Cost-Benefit Analysis

KW - Diffusion Magnetic Resonance Imaging

KW - Humans

KW - Magnetic Resonance Imaging

KW - Magnetic Resonance Spectroscopy

KW - Male

KW - Prostate

KW - Prostatic Neoplasms

U2 - 10.3310/hta17200

DO - 10.3310/hta17200

M3 - Article

C2 - 23697373

SN - 1366-5278

VL - 17

SP - vii-xix, 1-281

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 20

ER -

Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C et al. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation. Health Technology Assessment. 2013 May;17(20):vii-xix, 1-281. doi: 10.3310/hta17200